Sulmasy D P, Sugarman J
Division of General Internal Medicine, Georgetown University Medical Center, Washington, DC.
J Med Ethics. 1994 Dec;20(4):218-22; discussion 223-4. doi: 10.1136/jme.20.4.218.
Many medical ethicists accept the thesis that there is no moral difference between withholding and withdrawing life-sustaining therapy. In this paper, we offer an interesting counterexample which shows that this thesis is not always true. Withholding is distinguished from withdrawing by the simple fact that therapy must have already been initiated in order to speak coherently about withdrawal. Provided that there is a genuine need and that therapy is biomedically effective, the historical fact that therapy has been initiated entails a claim to continue therapy that cannot be attributed to patients who have not yet received therapy. This intrinsic difference between withholding and withdrawing therapy is of moral importance. In many instances, patients will waive this claim. But when one considers withdrawing therapy from one patient to help another in a setting of scarce resources, this intrinsic moral difference comes into sharp focus. In an era of shrinking medical resources, this difference cannot be ignored.
在停止和撤销维持生命的治疗之间不存在道德差异。在本文中,我们给出了一个有趣的反例,表明这一观点并非总是正确的。停止与撤销的区别在于一个简单的事实,即必须已经开始治疗,才能连贯地谈论撤销治疗。假设存在真正的需求且治疗在生物医学上是有效的,治疗已经开始这一历史事实意味着有继续治疗的权利,而这一权利不能归于尚未接受治疗的患者。停止和撤销治疗之间的这种内在差异具有道德重要性。在许多情况下,患者会放弃这一权利。但是,当考虑在资源稀缺的情况下从一名患者身上撤销治疗以帮助另一名患者时,这种内在的道德差异就会凸显出来。在医疗资源不断缩减的时代,这种差异不容忽视。